Filing Details
- Accession Number:
- 0000879169-24-000174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-08 12:48:59
- Reporting Period:
- 2024-11-06
- Accepted Time:
- 2024-11-08 12:48:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1615842 | P Barry Flannelly | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Manager Us | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-06 | 1,424 | $72.27 | 59,466 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-11-06 | 2,256 | $68.62 | 61,722 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-11-06 | 1,424 | $82.00 | 60,298 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-06 | 2,256 | $78.21 | 58,042 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-11-06 | 1,424 | $0.00 | 1,424 | $72.27 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2024-11-06 | 2,256 | $0.00 | 2,256 | $68.62 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2029-01-03 | No | 4 | M | Direct | |
0 | 2028-07-01 | No | 4 | M | Direct |
Footnotes
- This includes an aggregate of 46,105 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
- Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.
- Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.